System1 Biosciences
San Francisco
About System1 Biosciences
System1 Biosciences, Inc., is a San Francisco-based neurotherapeutics company that employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least successful. System1 combines cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to discover characterizations of disease never before achievable. These “deep phenotypes” are exploited to identify novel therapeutic targets and drug treatments.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 10,001+
- Estimated revenue: $10K – $50K
- Total funding: $25.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2018)
- Website: system1.bio
Industries & Categories
Biotechnology, Neuroscience, Therapeutics
Canonical: https://fsome.com/organization/system1-biosciences-190147 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.